Jim Cramer on Medtronic: “This Long-Term Winner’s Become a Short-Term Loser”
Key takeaways
- Cramer highlighted the company’s share price performance, as he said:
- Speaking of jarring, this long-term winner’s become a short-term loser with the stock down 23% year to date.
- Medtronic plc (NYSE:MDT) develops and sells device-based medical therapies to healthcare systems, physicians, and patients.
Jim Cramer on Medtronic: “This Long-Term Winner’s Become a Short-Term Loser” Syeda Seirut Javed Tue, June 2, 2026 at 12:42 AM GMT+7 2 min read MDT BSX Medtronic plc (NYSE:MDT) was among the stocks Jim Cramer was focused on, as he discussed Mad Money’s latest game plan for the week. Cramer highlighted the company’s share price performance, as he said:
Wednesday morning, Medtronic reports. Speaking of jarring, this long-term winner’s become a short-term loser with the stock down 23% year to date. Medtronic is not alone; most of the medical device stocks are down with the worst being one of the best just last year, Boston Scientific, almost 50% down. I wish I could be aggressive in recommending Medtronic on Monday morning, but I can’t. Right now, we gotta wait to see the quarter. That group’s so awful.
Stock market data. Photo by Jakub Zerdzicki on Pexels